CD4 and acute myeloid leukemia: Although there was no significant difference in CD4 + PD1 + levels among AML patients of different disease types (Fig. 5G), the CD8+ PD1+ levels of M2 AML patients were significantly higher than those of M4 (p < 0.01) (Fig. 5H).